These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36279983)

  • 21. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.
    Zheng C; Zheng L; Yoo JK; Guo H; Zhang Y; Guo X; Kang B; Hu R; Huang JY; Zhang Q; Liu Z; Dong M; Hu X; Ouyang W; Peng J; Zhang Z
    Cell; 2017 Jun; 169(7):1342-1356.e16. PubMed ID: 28622514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
    Wu K; Kryczek I; Chen L; Zou W; Welling TH
    Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tc17 CD8 T cells: functional plasticity and subset diversity.
    Yen HR; Harris TJ; Wada S; Grosso JF; Getnet D; Goldberg MV; Liang KL; Bruno TC; Pyle KJ; Chan SL; Anders RA; Trimble CL; Adler AJ; Lin TY; Pardoll DM; Huang CT; Drake CG
    J Immunol; 2009 Dec; 183(11):7161-8. PubMed ID: 19917680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma.
    Li J; Huang ZF; Xiong G; Mo HY; Qiu F; Mai HQ; Chen QY; He J; Chen SP; Zheng LM; Qian CN; Zeng YX
    J Transl Med; 2011 Nov; 9():189. PubMed ID: 22051182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-γ- and IL-17-producing CD8
    Ohkuri T; Kosaka A; Ikeura M; Salazar AM; Okada H
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34193567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
    Wang W; Wu J; Ji M; Wu C
    J Transl Med; 2020 Dec; 18(1):477. PubMed ID: 33308251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
    Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
    Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.
    Hansler J; Wissniowski TT; Schuppan D; Witte A; Bernatik T; Hahn EG; Strobel D
    World J Gastroenterol; 2006 Jun; 12(23):3716-21. PubMed ID: 16773688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC.
    Suthen S; Lim CJ; Nguyen PHD; Dutertre CA; Lai HLH; Wasser M; Chua C; Lim TKH; Leow WQ; Loh TJ; Wan WK; Pang YH; Soon G; Cheow PC; Kam JH; Iyer S; Kow A; Tam WL; Shuen TWH; Toh HC; Dan YY; Bonney GK; Chan CY; Chung A; Goh BKP; Zhai W; Ginhoux F; Chow PKH; Albani S; Chew V
    Hepatology; 2022 Nov; 76(5):1329-1344. PubMed ID: 35184329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-7 enhances anti-tumor activity of CD8
    Teng D; Ding L; Cai B; Luo Q; Wang H
    Cytokine; 2019 Jun; 118():115-123. PubMed ID: 29655570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.
    Liu X; Ren H; Guo H; Wang W; Zhao N
    Clin Exp Immunol; 2021 Feb; 203(2):219-229. PubMed ID: 33030251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.
    Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB
    Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma.
    Wang H; Fu Y; Da BB; Xiong G
    J Healthc Eng; 2022; 2022():8256314. PubMed ID: 35449866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection.
    Nigam P; Kwa S; Velu V; Amara RR
    J Immunol; 2011 Jan; 186(2):745-53. PubMed ID: 21148794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
    Sandhu A; Ahmad S; Kaur P; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2019 Jan; 38(1):37-44. PubMed ID: 29464523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
    Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
    Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleural mesothelial cells promote expansion of IL-17-producing CD8+ T cells in tuberculous pleural effusion.
    Li X; Zhou Q; Yang WB; Xiong XZ; Du RH; Zhang JC
    J Clin Immunol; 2013 May; 33(4):775-87. PubMed ID: 23299924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.